biotheryx.comHealthcare / BioTech & PharmaFounded: 2007Funding to Date: $173.09MM
BioTheryX restores protein homeostasis through protein modulation, including protein degradation as well as multi-kinase inhibition, to develop treatments that extend and improve the quality-of-life of patients with life-threatening diseases.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/20/2021 | Series E | $100MM | $xx.xx | $348.42MM | Alexandria Ventur Investors, Avidity Partners, Deep Track Capital, Farallon Capital Management, Irving Investors, Janus Henderson Investors, Lumira Ventures, Point72, Rock Springs Capital, Surveyor Capital, Tekla Capital Management, Wedbush Helthcare Partners | |
Price per Share
$xx.xx
Shares Outstanding
19,047,619
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Ventur Investors, Avidity Partners, Deep Track Capital, Farallon Capital Management, Irving Investors, Janus Henderson Investors, Lumira Ventures, Point72, Rock Springs Capital, Surveyor Capital, Tekla Capital Management, Wedbush Helthcare Partners
|
||||||
07/28/2020 | Series D | $38.5MM | $xx.xx | $307.61MM | Msd Partners L.P | |
Price per Share
$xx.xx
Shares Outstanding
5,310,344
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Msd Partners L.P
|
||||||
02/28/2017 | Series C | $15MM | $xx.xx | $74.18MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,500,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
11/12/2015 | Series B | $15.09MM | $xx.xx | $37.89MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,918,436
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
11/30/2010 | Series A | $4.5MM | $xx.xx | $15MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
2.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|